Lactate as a novel quantitative measure of viability in Schistosoma mansoni drug sensitivity assays

Antimicrobial Agents and Chemotherapy

Volumn 59, Issue 2, 2015, Pages 1193-1199

  Howe, Stephanie ^a   Zöphel, Dorina ^a   Subbaraman, Harini ^a   Unger, Clemens ^a   Held, Jana ^a   Engleitner, Thomas ^a   Hoffmann, Wolfgang H ^a   Kreidenweissa, Andrea ^a,b  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b Centre de Recherche Médicale de Lambaréné CERMEL   (Gabon)

Author keywords

[No Author keywords available]

Indexed keywords

AURANOFIN; GAMBOGIC ACID; LACTIC ACID; MEFLOQUINE; NICLOSAMIDE; PRAZIQUANTEL; SALINOMYCIN; ANTHELMINTIC AGENT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SCREENING; DRUG SENSITIVITY; EX VIVO STUDY; GLUCOSE METABOLISM; GLYCOLYSIS; IC50; MALE; MICROBIAL VIABILITY; MOUSE; NONHUMAN; PARASITE SURVIVAL; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SCHISTOSOMA MANSONI; SCHISTOSOMULUM; ANIMAL; DRUG EFFECTS; METABOLISM; MICROSCOPY; PRECLINICAL STUDY;

ANIMALS; ANTHELMINTICS; DRUG EVALUATION, PRECLINICAL; LACTIC ACID; MICROSCOPY; SCHISTOSOMA MANSONI;

EID: 84921768022     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.03809-14     Document Type: Article

References (32)

1. Hotez PJ, Fenwick A, Savioli L, Molyneux DH. 2009. Rescuing the bottom billion through control of neglected tropical diseases. Lancet 373: 1570-1575. http://dx.doi.org/10.1016/S0140-6736(09)60233-6.
2. Doenhoff MJ, Pica-Mattoccia L. 2006. Praziquantel for the treatment of schistosomiasis: its use for control in areas with endemic disease and prospects for drug resistance. Expert Rev Anti Infect Ther 4:199-210. http://dx .doi.org/10.1586/14787210.4.2.199.
3. WHO. 2013. Schistosomiasis: number of people treated in 2011. Wkly Epidemiol Rec 88:81-88.
4. WHO. 2013. New agreement expands access to schistosomiasis treatment for millions. WHO, Geneva, Switzerland. http://www.who.int/neglected -diseases/schistosomiasis-Merck-2013/en/index.html. Accessed 2 October 2013.
5. Fallon PG, Sturrock RF, Niang AC, Doenhoff MJ. 1995. Short report: diminished susceptibility to praziquantel in a Senegal isolate of Schistosoma mansoni. Am J Trop Med Hyg 53:61-62.
6. De Clercq D, Vercruysse J, Picquet M, Shaw DJ, Diop M, Ly A, Gryseels B. 1999. The epidemiology of a recent focus of mixed Schistosoma haematobium and Schistosoma mansoni infections around the 'Lac de Guiers' in the Senegal River Basin, Senegal. Trop Med Int Health 4:544-550. http: //dx.doi.org/10.1046/j.1365-3156.1999.00444.x.
7. Wang W, Wang L, Liang Y-S. 2012. Susceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res 111:1871-1877. http://dx.doi.org/10.1007/s00436-012-3151-z.
8. Keiser J. 2010. In vitro and in vivo trematode models for chemotherapeutic studies. Parasitology 137:589-603. http://dx.doi.org/10.1017/S003118 2009991739.
9. Lee H, Moody-Davis A, Saha U, Suzuki BM, Asarnow D, Chen S, Arkin M, Caffrey CR, Singh R. 2012. Quantification and clustering of phenotypic screening data using time-series analysis for chemotherapy of schistosomiasis. BMC Genomics 13(Suppl 1):S4. http://dx.doi.org/10.1186 /1471-2164-13-S1-S4.
10. Magalhães LG, Machado CB, Morais ER, de Carvalho Moreira EB, Soares CS, da Silva SH, Da Silva-Filho AA, Rodrigues V. 2009. In vitro schistosomicidal activity of curcumin against Schistosoma mansoni adult worms. Parasitol Res 104:1197-1201. http://dx.doi.org/10.1007/s00436 -008-1311-y.
11. Manneck T, Braissant O, Haggenmüller Y, Keiser J. 2011. Isothermal microcalorimetry to study drugs against Schistosoma mansoni. J Clin Microbiol 49:1217-1225. http://dx.doi.org/10.1128/JCM.02382-10.
12. Mansour NR, Bickle QD. 2010. Comparison of microscopy and Alamar blue reduction in a larval based assay for schistosome drug screening. PLoS Negl Trop Dis 4:e795. http://dx.doi.org/10.1371/journal.pntd.0000795.
13. Peak E, Chalmers IW, Hoffmann KF. 2010. Development and validation of a quantitative, high-throughput, fluorescent-based bioassay to detect schistosoma viability. PLoS Negl Trop Dis 4:e759. http://dx.doi.org/10 .1371/journal.pntd.0000759.
14. McCarthy M. 2007. The Global Fund: 5 years on. Lancet 370:307-308. http://dx.doi.org/10.1016/S0140-6736(07)61144-1.
15. Manneck T, Braissant O, Ellis W, Keiser J. 2011. Schistosoma mansoni: antischistosomal activity of the four optical isomers and the two racemates of mefloquine on schistosomula and adult worms in vitro and in vivo. Exp Parasitol 127:260-269. http://dx.doi.org/10.1016/j.exppara.2010.08.011.
16. Paveley RA, Mansour NR, Hallyburton I, Bleicher LS, Benn AE, Mikic I, Guidi A, Gilbert IH, Hopkins AL, Bickle QD. 2012. Whole organism high-content screening by label-free, image-based Bayesian classification for parasitic diseases. PLoS Negl Trop Dis 6:e1762. http://dx.doi.org/10 .1371/journal.pntd.0001762.
17. Collins JJ, Wang B, Lambrus BG, Tharp ME, Iyer H, Newmark PA. 2013. Adult somatic stem cells in the human parasite Schistosoma mansoni. Nature 494:476-479. http://dx.doi.org/10.1038/nature11924.
18. Shaw MK, Erasmus DA. 1987. Schistosoma mansoni: structural damage and tegumental repair after in vivo treatment with praziquantel. Parasitology 94(Pt 2):243-254. http://dx.doi.org/10.1017/S0031182000053920.
19. Shapiro TA, Talalay P. 1982. Schistosoma mansoni: mechanisms in regulation of glycolysis. Exp Parasitol 54:379-390. http://dx.doi.org/10.1016 /0014-4894(82)90047-9.
20. Thompson DP, Morrison DD, Pax RA, Bennett JL. 1984. Changes in glucose metabolism and cyanide sensitivity in Schistosoma mansoni during development. Mol Biochem Parasitol 13:39-51. http://dx.doi.org/10 .1016/0166-6851(84)90100-2.
21. Bueding E. 1950. Carbohydrate metabolism of Schistosoma mansoni. J Gen Physiol 33:475-495. http://dx.doi.org/10.1085/jgp.33.5.475.
22. Krautz-Peterson G, Simoes M, Faghiri Z, Ndegwa D, Oliveira G, Shoemaker CB, Skelly PJ. 2010. Suppressing glucose transporter gene expression in schistosomes impairs parasite feeding and decreases survival in the mammalian host. PLoS Pathog 6:e1000932. http://dx.doi.org/10.1371 /journal.ppat.1000932.
23. Horemans AM, Tielens AG, van den Bergh SG. 1992. The reversible effect of glucose on the energy metabolism of Schistosoma mansoni cercariae and schistosomula. Mol Biochem Parasitol 51:73-79. http://dx.doi.org /10.1016/0166-6851(92)90202-U.
24. Faghiri Z, Camargo SMR, Huggel K, Forster IC, Ndegwa D, Verrey F, Skelly PJ. 2010. The tegument of the human parasitic worm Schistosoma mansoni as an excretory organ: the surface aquaporin SmAQP is a lactate transporter. PLoS One 5:e10451. http://dx.doi.org/10.1371/journal.pone .0010451.
25. Massie CE, Lynch A, Ramos-Montoya A, Boren J, Stark R, Fazli L, Warren A, Scott H, Madhu B, Sharma N, Bon H, Zecchini V, Smith D-M, Denicola GM, Mathews N, Osborne M, Hadfield J, Macarthur S, Adryan B, Lyons SK, Brindle KM, Griffiths J, Gleave ME, Rennie PS, Neal DE, Mills IG. 2011. The androgen receptor fuels prostate cancer by regulating central metabolism and biosynthesis. EMBO J 30:2719-2733. http://dx.doi.org/10.1038/emboj.2011.158.
26. Ramalho-Pinto FJ, Gazzinelli G, Howells RE, Mota-Santos TA, Figueiredo EA, Pellegrino J. 1974. Schistosoma mansoni: defined system for stepwise transformation of cercaria to schistosomule in vitro. Exp Parasitol 36:360-372. http://dx.doi.org/10.1016/0014-4894(74)90076-9.
27. Abdulla M-H, Ruelas DS, Wolff B, Snedecor J, Lim K-C, Xu F, Renslo AR, Williams J, McKerrow JH, Caffrey CR. 2009. Drug discovery for schistosomiasis: hit and lead compounds identified in a library of known drugs by medium-throughput phenotypic screening. PLoS Negl Trop Dis 3:e478. http://dx.doi.org/10.1371/journal.pntd.0000478.
28. R Development Core Team. 2008. R: a language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.
29. Faghiri Z, Skelly PJ. 2009. The role of tegumental aquaporin from the human parasitic worm, Schistosoma mansoni, in osmoregulation and drug uptake. FASEB J 23:2780-2789. http://dx.doi.org/10.1096/fj.09-130757.
30. Sabah AA, Fletcher C, Webbe G, Doenhoff MJ. 1986. Schistosoma mansoni: chemotherapy of infections of different ages. Exp Parasitol 61: 294-303. http://dx.doi.org/10.1016/0014-4894(86)90184-0.
31. Doenhoff MJ, Cioli D, Utzinger J. 2008. Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasis. Curr Opin Infect Dis 21:659-667. http://dx.doi.org/10.1097/QCO.0b013e328318978f.
32. Manneck T, Haggenmüller Y, Keiser J. 2010. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosoma mansoni. Parasitology 137:85-98. http://dx.doi.org /10.1017/S0031182009990965.